Literature DB >> 16527882

An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period.

M Adler1, S Chambers, C Edwards, G Neild, D Isenberg.   

Abstract

OBJECTIVES: Although the prognosis for patients with renal lupus has improved, a small number still progress to renal failure. Studies from the USA have found it difficult to distinguish whether the higher rate of renal failure in African-Americans is due to genetic or socio-economic factors. Our aim was to identify ethnic and other factors in a UK lupus cohort that contribute to renal failure.
METHODS: The University College London (UCL) Hospitals lupus cohort of 401 patients (Whites 64%, Blacks 19%), followed since 1978, has 127 patients with renal disease, of whom 21 have gone into renal failure. We determined the characteristics and possible causes of renal failure in this group. Black patients were disproportionately represented in the renal failure group (62% vs 19% for Whites).
RESULTS: Those in the renal failure group had persistently low C3 compared with the renal disease cohort. A high proportion of patients in the renal failure group were felt to be non-adherent to treatment.
CONCLUSIONS: Given that health-care for patients in the UK is free at the point of delivery, we postulate that in our cohort genetic factors rather than socio-economic status are likely to be more significant in causing renal failure. However, there may be cultural and other reasons for this, which requires further study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16527882     DOI: 10.1093/rheumatology/kel039

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  41 in total

1.  Identification and validation of lupus nephritis cases using administrative data.

Authors:  L B Chibnik; E M Massarotti; K H Costenbader
Journal:  Lupus       Date:  2010-02-23       Impact factor: 2.911

2.  Depression and medication nonadherence in childhood-onset systemic lupus erythematosus.

Authors:  A M Davis; T B Graham; Y Zhu; M L McPheeters
Journal:  Lupus       Date:  2018-06-28       Impact factor: 2.911

3.  Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis.

Authors:  Melanie S Joy; Mary La; Jinzhao Wang; Arlene S Bridges; Yichun Hu; Susan L Hogan; Reginald F Frye; Joyce Blaisdell; Joyce A Goldstein; Mary Anne Dooley; Kim L R Brouwer; Ronald J Falk
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

4.  Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis.

Authors:  Jose A Gómez-Puerta; Candace H Feldman; Graciela S Alarcón; Hongshu Guan; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-10       Impact factor: 4.794

5.  Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.

Authors:  Karen H Costenbader; Amrita Desai; Graciela S Alarcón; Linda T Hiraki; Tamara Shaykevich; M Alan Brookhart; Elena Massarotti; Bing Lu; Daniel H Solomon; Wolfgang C Winkelmayer
Journal:  Arthritis Rheum       Date:  2011-06

6.  End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.

Authors:  Linda T Hiraki; Bing Lu; Steven R Alexander; Tamara Shaykevich; Graciela S Alarcón; Daniel H Solomon; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2011-07

7.  Access to care and the incidence of endstage renal disease due to systemic lupus erythematosus.

Authors:  Michael M Ward
Journal:  J Rheumatol       Date:  2010-04-15       Impact factor: 4.666

8.  Depression, medication adherence, and service utilization in systemic lupus erythematosus.

Authors:  Laura J Julian; Edward Yelin; Jinoos Yazdany; Pantelis Panopalis; Laura Trupin; Lindsey A Criswell; Patricia Katz
Journal:  Arthritis Rheum       Date:  2009-02-15

9.  Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004.

Authors:  Candace H Feldman; Linda T Hiraki; Jun Liu; Michael A Fischer; Daniel H Solomon; Graciela S Alarcón; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2013-03

10.  Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study.

Authors:  David Isenberg; Gerald B Appel; Gabriel Contreras; Mary A Dooley; Ellen M Ginzler; David Jayne; Jorge Sánchez-Guerrero; David Wofsy; Xueqing Yu; Neil Solomons
Journal:  Rheumatology (Oxford)       Date:  2009-11-20       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.